USE OF ESTROGENIC COMPOUNDS IN COMBINATION WITH PROGESTOGENIC COMPOUNDS IN HORMONEREPLACEMENT THERAPY

Details for Australian Patent Application No. 2002311678 (hide)

Owner PANTARHEI BIOSCIENCE B.V.

Inventors COELINGH BENNINK, Herman, Jan, Tijmen; BUNSCHOTEN, Evert, Johannes; HOLINKA, Christian, Franz

Pub. Number AU-A-2002311678

PCT Number PCT/NL02/00333

PCT Pub. Number WO2003/018026

Priority 01203305.6 31.08.01 EP; 01204377.4 15.11.01 EP

Filing date 23 May 2002

Wipo publication date 10 March 2003

International Classifications

A61K 031/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61P 005/30 Drugs for disorders of the endocrine system

A61K 031/57 - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 01203305.6 31.08.01 EP; 01204377.4 15.11.01 EP

5 June 2003 Application Open to Public Inspection

  Published as AU-A-2002311678

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002311679-A DIFFERENTIAL LABELLING METHOD

2002311677-USE OF ESTROGENIC COMPOUNDS IN COMBINATION WITH PROGESTOGENIC COMPOUNDS IN HORMONEREPLACEMENT THERAPY